Mukka Proteins reappoints directors for five-year terms at AGM
- Mukka Proteins shareholders reappointed all independent and executive directors for five-year terms
- New director terms commence in January 2027, extending leadership stability through 2032
- Shareholders approved an increase in the company's overall borrowing limit
- FY26 audited financial statements were ratified without qualification by statutory auditors
- Related party transactions with four entities received shareholder approval
*this image is generated using AI for illustrative purposes only.
Mukka Proteins shareholders approved the reappointment of its entire board of independent and executive directors for five-year terms during its 16th Annual General Meeting held on September 10, 2026.
The virtual meeting also saw shareholders ratify the audited standalone and consolidated financial statements for FY26, which received no qualifications from statutory auditors Shah & Taparia. Additionally, the company secured approval for an increase in its overall borrowing limit and related party transactions.
Key Resolutions Passed
The company secured approval for multiple special and ordinary resolutions critical to its operational flexibility and governance structure.
| Resolution Type | Key Action | Details |
|---|---|---|
| Special | Borrowing Limit | Approved increase under Section 180(1)(c) of Companies Act, 2013 |
| Special | Asset Charge | Approved creation of mortgage/charge on assets under Section 180(1)(a) |
| Ordinary | Related Party | Approved transactions with Atlantic Marine Products, Progress Frozen, Ullal Fish Meal, and Mangalore Fish Meal |
Board and Management Reappointments
Shareholders reappointed three independent directors: Karkala Shankar Balachandra Rao, Hamad Bava, and Narendra Surendra Kamath. All three will serve a second term of five consecutive years commencing from January 15, 2027, to January 14, 2032. None are liable to retire by rotation.
Executive leadership renewals included Managing Director and CEO Kalandan Mohammed Haris, CFO Kalandan Mohammed Althaf, and COO Kalandan Mohammad Arif. Their terms are set for five years, effective from January 20, 2027, to January 19, 2032. While Haris is not liable to retire by rotation, Althaf and Arif are liable to do so.
Additionally, Whole-Time Director Kalandan Mohammad Arif and Non-Executive Director Mrs. Umaiyya Banu were reappointed following retirement by rotation.
Meeting Participation
Fifty-nine members attended the virtual AGM, comprising five promoter group representatives and 54 public shareholders. The quorum was present from the start, allowing proceedings to commence promptly at 3:00 pm. Statutory Auditors Shah & Taparia and Secretarial Auditor Chethan Nayak & Associates were present to address queries regarding their reports.
Historical Stock Returns for Mukka Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.38% | +13.85% | +30.59% | +41.46% | +10.12% | 0.0% |
How will the increased borrowing limit and asset charges influence Mukka Proteins' capital expenditure plans for capacity expansion or technology upgrades?
What strategic synergies are expected from the approved related-party transactions with Atlantic Marine Products and other affiliated entities?
How might the reappointment of the entire executive board impact the company's long-term strategic direction and operational stability in the competitive protein market?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
